BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $378,000 | -59.5% | 2,500 | -60.9% | 0.04% | -57.0% |
| Q2 2022 | $933,000 | -22.8% | 6,400 | -37.3% | 0.09% | -9.5% |
| Q1 2022 | $1,209,000 | -15.2% | 10,200 | -1.4% | 0.10% | -14.4% |
| Q4 2021 | $1,426,000 | -2.7% | 10,350 | -1.9% | 0.11% | -9.8% |
| Q3 2021 | $1,466,000 | +27.9% | 10,550 | -10.6% | 0.12% | +35.2% |
| Q2 2021 | $1,146,000 | +74.7% | 11,800 | +22.9% | 0.09% | +59.6% |
| Q1 2021 | $656,000 | +50.1% | 9,600 | +88.2% | 0.06% | +35.7% |
| Q4 2020 | $437,000 | +113.2% | 5,100 | +82.1% | 0.04% | +68.0% |
| Q2 2020 | $205,000 | – | 2,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |